| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |